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Association and interaction analyses of eight genes under asthma
linkage peaks
Allergic asthma is a heritable chronic disease that aﬀects
>10% of children in developed countries (1), many of
whom do not respond to the few established treatments
(2). In spite of a large public health burden, our
knowledge of the aetiological mechanisms underlying
asthma, both genetic and environmental, is still very
limited. One of the most promising approaches to further
our understanding of the disease mechanisms involved is
the identiﬁcation of genetic variation that contributes to
asthma risk.
As demonstrated for other complex diseases (3),
genome-wide association studies (GWAS) are the most
successful gene mapping approach currently available to
identify systematically all pathways at which genetic
variation contributes to disease risk. However, given the
multiple testing burden associated with GWAS and the
small eﬀect sizes that are predicted for most risk loci, the
success of this approach rests on the ability to analyse
data for many thousands of samples, for both the initial
discovery and replication stages.
While adequately powered datasets are being collected
for such large-scale hypothesis-free analyses, smaller,
more focused association studies can still provide a
valuable framework to investigate speciﬁc genetic hypoth-
eses. In this report, we screened eight genes that were
selected based on their potential functional relevance
from four regions previously reported to be linked to
asthma traits. Amongst these were known candidate
genes for asthma, namely the CD28, cytotoxic T-lym-
phocyte-associated protein 4 (CTLA4) and inducible
T-cell co-stimulator (ICOS) genes, but also new genes
not previously tested in the literature, including ADAM
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metallopeptidase domain 23 (ADAM23) and histamine
receptor H3 (HRH3). We employed novel association
methods and tested for gene-by-gene and gene-by-
environment interaction eﬀects to asses the inﬂuence of
genetic variants in these genes with both self-reported and
clinical measures of asthma in 5470 individuals.
Material and methods
Selection of genes for analysis
Our aim was to investigate the association between speciﬁc asthma
traits and genes located in four chromosomal regions identiﬁed
through previous linkage studies (Table 1). Genes were selected
from these regions for single nucleotide polymorphism (SNP)
genotyping based on their potential functional relevance and
included CD28, CTLA4, ICOS and ADAM23 on chromosome
2q33; ADAMTS-like 1 (ADAMTSL1) on 9p21; membrane-span-
ning 4-domains, subfamily A, member 2 (MS4A2, previously named
b chain of the high-aﬃnity IgE receptor, FCER1B) on 11q13; and
cadherin-like 26 (CDH26) and HRH3 on 20q13.
Samples
We genotyped samples drawn from two studies conducted at the
Queensland Institute of Medical Research (QIMR), Australia, a
study conducted at the VU University (VU), the Netherlands, and a
study conducted at the Bispebjerg Hospital (BH), Denmark. The
ﬁrst QIMR study (AS) included data for 735 families that are part
of a larger collection of pedigrees ascertained through an asthma
twin proband and described elsewhere (4). A subset of this sample
was used in the analysis that reported linkage of multiple asthma
traits to 20q13 (5). For the QIMR second study (TM), data were
available for 427 families that were recruited as part of an ongoing
study of melanocytic naevi (moles). Data from this panel were in-
cluded in the genome-wide linkage scan that implicated chromo-
some 2q33 in the regulation of basal eosinophil levels (6). The VU
sample consisted of 99 families ascertained as part of an ongoing
survey study of health-related behaviour (7), whereas the BH sam-
ple included data for 303 families ascertained through an asthma
twin proband as described previously (8). The characteristics of
the study participants are summarized in Supporting Information
Table S1. This study was performed with the ethical approval of all
institutions involved and with the written informed consent of all
participants.
Phenotypes
The asthma traits measured in the AS, VU and BH studies that are
relevant for the present analyses are doctor-diagnosed Asthma,
bronchial hyperresponsiveness (BHR), Atopy, skin prick test to
house dust mite (Dpter) and the four continuous traits forced
expiratory volume in 1 s (FEV1), FEV1 divided by forced vital
capacity (FEV1/FVC), total IgE and eosinophil (AS and VU only)
levels. All traits were measured or deﬁned using equivalent proto-
cols in all studies. These are described elsewhere for the AS (4) and
BH (8) studies and provided as Supplementary Methods for the VU
study. Haematology data, including eosinophil levels, were collected
for the TM study when twins were aged 12, 14 and 16 as described
previously (6).
For the 2q33 region, the phenotypes selected for analysis were
Dpter, FEV1/FVC, IgE and eosinophil levels, as these were the traits
previously reported to be linked (6, 9, 10) or associated (11, 12) to
this region. For the TM study, we selected the age 12 eosinophil data
as this was the time point at which signiﬁcant linkage was detected to
chromosome 2q33 (6). Similarly, we selected IgE for analysis with
9p21 (M. A. R. Ferreira, D. L. Duﬀy, N. G. Martin, unpublished
data), IgE and Atopy with 11q13 (11, 13, 14), and Dpter, atopy,
BHR, FEV1, asthma and FEV1/FVC for 20q13 (5).
Continuous traits were normalized and adjusted for signiﬁcant
covariates, which included age, gender, height (FEV1 only) and
regular smoking (FEV1/FVC). As age showed a strong positive
correlation with FEV1 for individuals aged 6–20 years (younger
cohort) and a negative correlation for those aged >20 years, an
interaction term with a cohort indicator was also used to correct for
this eﬀect.
SNP genotyping and quality control (QC)
A set of 108 SNPs reported to be highly polymorphic in the NCBI
SNP Database and evenly spaced across each of the eight genes was
originally selected for genotyping in the AS study using the Mass-
ARRAYTM Sequenom system as described previously (15). A subset
of these was also genotyped in the TM (n = 39), VU (n = 41) and
BH (n = 41) studies. Genotyping was performed in ﬁve batches,
with QC analyses performed for each batch separately (see Table S2
for details) using PLINK (16) and PEDSTATS (17). Twenty SNPs
were genotyped in two or three (n = 1) batches to assess concor-
dance between genotyping events. After individual QC, data from
all batches were merged, resulting in a dataset with 5535 individuals
genotyped for 95 SNPs. The concordance rate between diﬀerent
diﬀerent genotyping events was 0.995. After data were merged, we
compared genotype calls for self-reported monozygotic (MZ) twin
pairs (n = 351, concordance 0.992) and (i) deleted all individuals
(n = 65) from families (n = 22) with MZ twins having >1 dis-
cordant genotype and (ii) set to missing any discordant genotype for
the remaining MZ pairs. We then used MERLIN (18) to detect and
delete unlikely genotypes (n = 1227) and to infer missing genotypes
using identical by descent (IBD) information (n = 17 755).
Excluding 1250 ungenotyped founders for whomMERLIN inferred
a small fraction of genotypes (a median of 5.3%), the ﬁnal dataset
consisted of 5470 individuals genotyped for 95 SNPs.
Table 1. Summary of study design
Region Linkage reference(s) Genes selected N SNPs genotyped Studies included Phenotypes tested
2q33 6, 9, 10 CD28, CTLA4, ICOS, ADAM23 70 AS, VU, BH and TM Dpter, FEV1/FVC, IgE, eosinophils
9p21 Unpublished ADAMTSL1 6 AS IgE
11q13 13, 14 MS4A2 6 AS Atopy, IgE
20q13 5 CDH26, HRH3 13 AS Dpter, Atopy, BHR, FEV1, Asthma, FEV1/FVC
AS, QIMR asthma study; VU, VU University study; BH, Bispebjerg Hospital study; TM, QIMR twin moles study; Dpter, skin prick test to house dust mite; FEV1/FVC, forced
expiratory volume in 1 s (FEV1) divided by forced vital capacity (FVC).
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Main association analyses
We tested the following four hypotheses: (i) variants in the selected
2q33 genes are associated with Dpter response, FEV1/FVC, total
serum IgE or eosinophil levels; (ii) variants in ADAMTSL1 (9p21)
are associated with IgE levels; (iii) variants in MS4A2 (11q13) are
associated with Atopy or IgE levels; and (iv) variants in CDH26 and
HRH3 genes (20q13) are associated with Dpter response, atopy,
BHR, FEV1, asthma or FEV1/FVC. Hypothesis (i) was tested in the
AS, VU, BH and TM (eosinophils) studies, whereas hypotheses (ii),
(iii) and (iv) were tested in the AS study only.
For hypotheses (i), (iii) and (iv), the association between indi-
vidual SNPs and all traits was tested using a recently described
multivariate test of association implemented in PLINK (19). For
these analyses, phenotype data for one twin from MZ pairs
was discarded (that with milder asthma symptoms). Association
between eosinophil levels and 2q33 SNPs in the TM study was
tested with MERLIN while accounting for IBD allele sharing
between relatives (20) and linkage disequilibrium (LD) between
markers (21) because of the strong linkage signal present in this
dataset (logarithm of odds, LOD > 3). The same approach was
used to test hypothesis (ii).
Gene-wide significance thresholds and power for the main
analyses
We adopted the concept of the gene as the unit of association (22).
To assess the overall evidence for association with a particular gene
given the genetic variation assayed, we used MERLIN to simulate
1000 datasets under the null hypothesis of no linkage or association,
while preserving the marker informativeness, spacing, missing data
patterns and LD between markers of the original dataset. Each
dataset was analysed as described above and the most signiﬁcant
P-value of all SNPs tested in each gene and analysis was retained.
The threshold for gene-wide signiﬁcance (i.e. gene-wide P = 0.05)
corresponded to the 95th percentile of the 1000 sorted P-values
retained for each gene and analysis. Thresholds ranged between
0.002 and 0.028.
To estimate the power of the proposed analyses, we simulated
1000 datasets consisting of an SNP marker and an associated
quantitative trait (40% heritable) with MERLIN, while preserving
the missing data patterns of the original data. Based on these
analyses, power (a = 0.001) to detect univariate association with
the AS (or AS + VU + BH) study was 0.034 (0.055) for a quan-
titative trait locus (QTL) explaining 0.1% of the trait variance,
0.500 (0.752) for a 0.5% QTL, 0.938 (0.981) for a 1% QTL and 1.00
(1.00) for a 2% QTL. Power for the TM study and the same QTL
variances was respectively 0.01, 0.05, 0.18 and 0.55.
Secondary analyses
We performed gene-by-gene and gene-by-environment interaction
analyses to address two additional hypotheses. The ﬁrst considered
the possibility that under speciﬁc genetic models with strong epi-
static eﬀects and weak or no main eﬀects, risk loci could be detected
through interaction but not association analyses (23, 24). Second,
that an association between the eight genes tested and atopy might
only be detected when considering individuals exposed to certain
environmental factors.
To investigate whether strong gene-by-gene eﬀects could be
detected, we focused on the Atopy trait, as this was the general
clinical phenotype reported to be linked with all four regions tested.
We selected a subset of 350 unrelated cases and 184 unrelated
controls from the AS study and tested pairwise SNP interactions
between the eight genes using logistic regression as implemented in
PLINK. A total of 3733 pair-wise SNP interactions were tested.
Given the sample size and number of tests performed, power was
only adequate to detect strong interaction eﬀects. For example,
assuming a disease prevalence of 30%, a genotype relative risk of
0.6 for each of the four possible interaction parameters (addi-
tive · additive, additive · dominant, dominant · additive, domi-
nant · dominant), no main eﬀects and a minor allele frequency of
0.25 for both loci, power to detect epistasis was 0.80 (with
a = 0.05/3733 = 1.3 · 10)5), while power to detect association to
either loci was 0.18 (a = 0.05/95 = 5.3 · 10)4).
To investigate the presence of gene-by-environment eﬀects, we
speciﬁcally tested whether SNPs were associated with atopy status
in individuals: (i) exclusively breastfed under the age of six months;
(ii) exposed to parental smoking under the age of 2 years; (iii) with
frequent chest infections under the age of two and (iv) who lived in a
carpeted house under the age of two. After appropriately deﬁning
cases (e.g. breastfed atopics) and controls (e.g. breastfed nonatop-
ics) within each family, association was tested using the DFAM test
implemented in PLINK, with an adaptive permutation procedure
used to assess signiﬁcance.
Results
Previous linkage and association studies implicated the
2q33 region in the regulation of Dpter response, FEV1/
FVC, IgE and eosinophil levels. We tested whether
variants in the 2q33 genes CD28, CTLA4, ICOS or
ADAM23 were associated with any of these four pheno-
types in the combined data from the AS, VU and BH
studies using a multivariate approach. The 70 SNPs
genotyped tagged (r2 > 0.8) between 44% and 79% of
the common [minor allele frequency (MAF) > 0.05]
variation reported for these genes in the HapMap CEPH
population. No single SNP exceeded the respective
threshold for gene-wide signiﬁcance (Table 2). The most
associated SNP was rs3181096 (multivariate P = 0.028),
which is located in the CD28 promoter region. The main
phenotype associated with rs3181096 was FEV1/FVC
(Table S3). A subset of 30 SNPs was also tested for
association with eosinophil levels in the TM study. This
SNP set provided a similar coverage for the CD28/
CTLA4/ICOS cluster (40–62%), but considerable less
for ADAM23 (7%). In spite of evidence for linkage to
this region (best LOD = 3.77, P = 1.5 · 10)5,
rs3732079), no single SNP was associated with eosino-
philia at a gene-wide signiﬁcant level (Table S4). Of
note, the most associated SNP was rs3181098 (univariate
P = 0.02), which is in near complete LD (r2 = 0.99)
with rs3181096 (P = 0.034).
Next, we investigated whether any of the six SNPs
genotyped in ADAMTSL1 (13% coverage) on chromo-
some 9p21 were associated with total serum IgE levels in
the AS study. This region and gene were selected based on
previous linkage results for a subset of samples from this
study. There was some evidence for linkage (best
LOD = 0.85, P = 0.024, rs1889007) but not association
(best P = 0.103) with the markers tested (Table S5).
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Chromosome 11q13 and theMS4A2 gene in particular
were amongst the ﬁrst loci implicated by linkage studies
in the regulation of IgE levels and the atopic response.
We applied the same multivariate approach to test the
association between MS4A2 SNPs and variation in IgE
levels or Atopy in the AS study. Of the six SNPs tested in
this gene (42% coverage), ﬁve were signiﬁcant at the
P < 0.05 level (all in strong LD, r2 > 0.8), with the
most associated SNP (rs502581, multivariate P = 0.010)
just reaching gene-wide signiﬁcance (P < 0.012). The
observed multivariate association signal to rs502581 was
driven by variation in total serum IgE levels but not
atopy status (Table S6), a result that we conﬁrmed using
standard univariate analysis (P = 0.015 and P = 0.857,
respectively). This SNP explained approximately 0.4% of
the phenotypic variation of IgE in the AS study. There
were no signiﬁcant maternal eﬀects at this locus for either
trait (not shown).
Finally, following our earlier report of linkage between
chromosome 20q13 and Dpter, Atopy, BHR, FEV1,
Asthma and FEV1/FVC, we tested these six phenotypes
for association with 13 SNPs genotyped in the CDH26
(13% coverage) and HRH3 (19%) genes in the AS study.
There was no overall evidence for association with either
gene after accounting for the number of SNPs tested
(Table S7). The most associated SNP was rs6062144
(multivariate P = 0.036), located approximately 8 kb
upstream of HRH3.
Given the largely negative results withmost genes tested,
we investigated whether strong gene-by-gene or gene-by-
environment eﬀects could be detected in the AS study. We
focused on the Atopy trait, as this was the general clinical
phenotype reported to be linked with the four regions
tested. No signiﬁcant pairwise interactions were detected
between the eight genes, after accounting for the number of
tests performed (Table S8). Similarly, no overall signiﬁcant
associations were detected with any gene after considering
breastfeeding under six months and smoking exposure, the
occurrence of chest infections or living in a carpeted house
under the age of 2 years (not shown).
Discussion
Functional (25–27) and linkage studies (6, 9, 10) pointed
towards a potential role of genetic variation in the CD28/
CTLA4/ICOS gene cluster on the development of allergic
disorders and many association studies have followed-up
on this hypothesis (Table S9). However, most of these
focused on a small set of variants that were tested in
relatively underpowered samples. In fact, the only
reported associations that would remain signiﬁcant after
a strict adjustment for multiple testing were between two
independent variants (r2 < 0.1) in CTLA4 (rs5742909
and rs231775) and IgE levels (11, 12) and between a
variant in ICOS (rs11883722) and cockroach skin prick
response (28). In our analyses, there was no evidence for
association between rs5742909 or rs11883722 and the
four asthma traits tested (Dpter, FEV1/FVC, IgE and
eosinophils). Similarly, there was no association with a
variant (rs231779) that is in complete LD with rs231775.
In addition to these negative results to speciﬁc variants
previously reported in the literature, there was no overall
evidence for association with seven of the eight genes
tested and the respective phenotypes when we considered
all genetic variation assayed in each gene. The only
exception was for the gene encoding the b chain of the
high-aﬃnity IgE receptor (MS4A2) on chromosome
11q13, which showed weak evidence for association with
total serum IgE at the gene-wide level. Although the
observed association would not remain signiﬁcant at the
experiment-wide level (given the number of genes tested),
it is consistent with the hypothesis that genetic variation
in this gene may have an eﬀect on the variation of IgE
levels, as suggested by others (11, 14).
Given the power provided by the sample size used and
analyses performed, we conclude that the individual
genetic variation assayed in the 2q33, 9p21 and 20q13
regions does not explain a large fraction (i.e. >1%) of the
variation in the quantitative traits tested or have a major
impact on asthma or atopy risk. However, given the
caveats of the present study, namely, the small number of
genes tested per region, the low SNP coverage provided
for some genes, the low power to detect weaker but more
realistic eﬀect sizes and the limited number of environ-
mental risk factors considered, the possibility remains
that risk variants in these regions may only be identiﬁed
using larger studies with improved power. Alternatively,
it is possible that some or all of these regions represented
false-positive results from previous linkage-analyses. In
Table 2. Summary of multivariate association results between four genes in the
2q33 region and four asthma traits (Dpter, FEV1/FVC, total IgE and eosinophils), in
the combined analysis of the AS, VU and BH studies
CD28 CTLA4 ICOS ADAM23
Start position, kb* 204, 239 204, 401 204, 470 206, 977
Length target sequence, kb 111 86 105 254
SNP set
N HapMap 68 81 93 123
N tested (in HapMap) 15 (13) 9 (9) 19 (14) 27 (26)
Coverage 0.79 0.62 0.48 0.44
Gene-wide significance threshold§ 0.004 0.006 0.003 0.003
N with multivariate P < 0.05 2 0 0 0
Top association result
SNP rs3181096 rs3087243 rs933988 rs3755224
Multivariate P-value 0.028 0.054 0.070 0.057
Associated trait(s) FEV1/FVC – – –
SNP, single nucleotide polymorphism.
*Start position and length are based on the b36 coordinates for the first and last
transcribed bases €40 kb.
Number of described common (minor allele frequency >0.05) SNPs located within
the target region in CEU HapMap population. Also includes SNPs genotyped in this
study that are not in the HapMap.
Proportion of CEU HapMap SNPs captured with r2 ‡ 0.8 by the SNPs tested.
§Estimated from 1000 simulated datasets using MERLIN. See Methods for details.
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this respect, combining data from published candidate-
gene studies and emerging GWAS will provide ample
opportunities to address some of these limitations.
Acknowledgments
The authors thank all families who participated in this study. The
authors also thank Dr Louise OGorman, Dr Peter Le Soue¨f, Dr
Paul R Burton, Dr Brett G Toelle, Dr Colin F Robertson, Dr Claire
Wainwright, Barbara Haddon, Dixie Statham, Wendy Oddy,
Sunalene Devadason, Dr Nigel Dore, Marita Dalton, Brigitte
Willemse, Elena Belousova, Janet Li and Dr Jennifer Peat for their
roles in phenotype collection, and Renee Mayne for DNA prepa-
ration and genotyping. Phenotype data analysed in this study were
originally collected with funding from Sequana Therapeutics Inc.
and later by AxyS Pharmaceutical Inc. Genotype collection and
data analysis were supported by Project Grant 290274 and a Sidney
Sax fellowship (to MARF) from the National Health and Medical
Research Council (NHMRC), Australia.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Supplementary Methods.
Table S1. Characteristics of the study participants for the
four individual studies.
Table S2.Details of the QC ﬁlters applied to the SNP data.
Table S3. Multivariate association results between four
asthma traits and CD28, CTLA4 119 and ICOS SNPs on
chromosome 2q33, for the combined analysis of the AS,
VU and BH studies.
Table S4. Univariate association results for the TM study
between eosinophil levels and 128 CD28, CTLA4 and
ICOS SNPs on chromosome 2q33.
Table S5. Univariate association results for the AS study
between IgE levels and 131 ADAMTSL1 SNPs on
chromosome 9p21.
Table S6. Multivariate association results for the AS
study betweenMS4A2 SNPs and 134 atopy and total IgE
levels.
Table S7. Multivariate association results for the AS
study between 20q13 SNPs and six 142 asthma traits.
Table S8. Gene-gene interaction results for atopy in the
AS study between all eight genes 152 tested.
Table S9. Summary of main results from published
candidate-gene gene association studies of asthma traits
and CD28, CTLA4 and ICOS polymorphisms.
Supplementary References.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials
supplied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
References
1. Asher MI, Montefort S, Bjo¨rkste´n B,
Lai CK, Strachan DP, Weiland SK et al.
Worldwide time trends in the prevalence
of symptoms of asthma, allergic rhino-
conjunctivitis, and eczema in childhood:
ISAAC phases one and three repeat
multicountry cross-sectional surveys.
Lancet 2006;368:733–743.
2. Holgate ST, Polosa R. Treatment strat-
egies for allergy and asthma. Nat Rev
Immunol 2008;8:218–230.
3. Altshuler D, Daly MJ, Lander ES.
Genetic mapping in human disease.
Science 2008;322:881–888.
4. Ferreira MA, OGorman L, Le Soue¨f P,
Burton PR, Toelle BG, Robertson CF
et al. Variance components analyses of
multiple asthma traits in a large sample
of Australian families ascertained
through a twin proband. Allergy
2006;61:245–253.
5. Ferreira MAR, OGorman L, Le Souef
P, Burton PR, Toelle BG, Robertson
CF et al. Robust estimation of experi-
ment-wise P-values applied to a
genome-scan of multiple asthma traits
identiﬁes a new region of signiﬁcant
linkage on chromosome 20q13. Am J
Hum Genet 2005;77:1075–1085.
6. Evans DM, Zhu G, Duﬀy DL,
Montgomery GW, Frazer IH, Martin
NG. Major quantitative trait locus for
eosinophil count is located on chromo-
some 2q. J Allergy Clin Immunol
2004;114:826–830.
7. Boomsma DI, de Geus EJ, Vink JM,
Stubbe JH, Distel MA, Hottenga JJ
et al. Netherlands Twin Register: from
twins to twin families. Twin Res Hum
Genet 2006;9:849–857.
8. Thomsen SF, Ulrik CS, Kyvik KO,
Ferreira MA, Backer V. Multivariate
genetic analysis of atopy phenotypes in
a selected sample of twins. Clin Exp
Allergy 2006;36:1382–1390.
9. Ober C, Tsalenko A, Parry R, Cox NJ.
A second-generation genomewide screen
for asthma-susceptibility alleles in a
founder population. Am J Hum Genet
2000;67:1154–1162.
10. Postma DS, Meyers DA, Jongepier H,
Howard TD, Koppelman GH, Bleecker
ER. Genome wide screen for pulmonary
function in 200 families ascertained for
asthma. Am J Respir Crit Care Med
2005;172:446–452.
11. Hizawa N, Yamaguchi E, Jinushi E,
Konno S, Kawakami Y, Nishimura M.
Increased total serum IgE levels in
patients with asthma and promoter
polymorphisms at CTLA4 and
FCER1B. J Allergy Clin Immunol
2001;108:74–79.
12. Howard TD, Postma DS, Koppelman
GA, Koppelman GH, Zheng SL,
Wysong AK et al. Fine mapping of an
IgE-controlling gene on chromosome
2q: Analysis of CTLA4 and CD28.
J Allergy Clin Immunol 2002;110:
743–751.
13. Sandford AJ, Shirakawa T, Moﬀatt
MF, Daniels SE, Ra C, Faux JA et al.
Localisation of atopy and beta subunit
of high-aﬃnity IgE receptor (Fc epsilon
RI) on chromosome 11q. Lancet 1993;
341:332–334.
14. Traherne JA, Hill MR, Hysi P,
DAmato M, Broxholme J, Mott R et al.
LD mapping of maternally and non-
maternally derived alleles and atopy in
FcepsilonRI-beta. Hum Mol Genet
2003;12:2577–2585.
Association mapping under asthma linkage peaks
 2009 John Wiley & Sons A/S Allergy 2009: 64: 1623–1628 1627
15. Montgomery GW, Zhao ZZ, Marsh AJ,
Mayne R, Treloar SA, James M et al. A
deletion mutation in GDF9 in sisters
with spontaneous DZ twins. Twin Res
2004;7:548–555.
16. Purcell S, Neale B, Todd-Brown K,
Thomas L, Ferreira MA, Bender D
et al. PLINK: a tool set for whole-
genome association and population-
based linkage analyses. Am J Hum
Genet 2007;81:559–575.
17. Wigginton JE, Abecasis GR. PED-
STATS: descriptive statistics, graphics
and quality assessment for gene
mapping data. Bioinformatics
2005;21:3445–3447.
18. Abecasis GR, Cherny SS, Cookson WO,
Cardon LR. Merlin – rapid analysis of
dense genetic maps using sparse gene
ﬂow trees. Nat Genet 2002;30:97–101.
19. Ferreira MA, Purcell SM. A multivari-
ate test of association. Bioinformatics
2009;25:132–133.
20. Chen WM, Abecasis GR. Family-based
association tests for genomewide asso-
ciation scans. Am J Hum Genet
2007;81:913–926.
21. Abecasis GR, Wigginton JE. Handling
marker-marker linkage disequilibrium:
pedigree analysis with clustered mark-
ers. Am J Hum Genet 2005;77:754–767.
22. Neale BM, Sham PC. The future of
association studies: gene-based analysis
and replication. Am J Hum Genet
2004;75:353–362.
23. Evans DM, Marchini J, Morris AP,
Cardon LR. Two-stage two-locus
models in genome-wide association.
PLoS Genet 2006;2:e157.
24. Marchini J, Donnelly P, Cardon LR.
Genome-wide strategies for detecting
multiple loci that inﬂuence complex
diseases. Nat Genet 2005;37:413–417.
25. Krinzman SJ, De Sanctis GT, Cernadas
M, Mark D, Wang Y, Listman J et al.
Inhibition of T cell costimulation abro-
gates airway hyperresponsiveness in a
murine model. J Clin Invest
1996;98:2693–2699.
26. Keane-Myers A, Gause WC, Linsley PS,
Chen SJ, Wills-Karp M. B7-CD28/
CTLA-4 costimulatory pathways are
required for the development of T helper
cell 2-mediated allergic airway responses
to inhaled antigens. J Immunol
1997;158:2042–2049.
27. Mathur M, Herrmann K, Qin Y,
Gulmen F, Li X, Krimins R et al. CD28
interactions with either CD80 or CD86
are suﬃcient to induce allergic airway
inﬂammation in mice. Am J Respir Cell
Mol Biol 1999;21:498–509.
28. Shilling RA, Pinto JM, Decker DC,
Schneider DH, Bandukwala HS,
Schneider JR et al. Cutting edge: Poly-
morphisms in the ICOS promoter
region are associated with allergic sen-
sitization and Th2 cytokine production.
J Immunol 2005;175:2061–2065.
Ferreira et al.
1628  2009 John Wiley & Sons A/S Allergy 2009: 64: 1623–1628
